Comparing the Outcomes of Patients With Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Bacteremia

Published on Feb 1, 2017in Clinical Infectious Diseases9.055
· DOI :10.1093/cid/ciw741
Pranita D. Tamma24
Estimated H-index: 24
(JHUSOM: Johns Hopkins University School of Medicine),
Katherine E. Goodman4
Estimated H-index: 4
(Johns Hopkins University)
+ 4 AuthorsPatricia J. Simner18
Estimated H-index: 18
(JHUSOM: Johns Hopkins University School of Medicine)
Abstract Carbapenem-resistant Enterobacteriaceae (CRE) are associated with considerable mortality. As mechanisms of carbapenem resistance are heterogeneous, it is unclear if mortality differs based on resistance mechanisms. We sought to determine whether CRE resistance mechanism determination is prognostically informative. We conducted an observational study comparing 14-day mortality between patients with carbapenemase-producing (CP)-CRE compared with non-CP-CRE bacteremia. Clinical data were collected on all patients. A comprehensive DNA microarray-based assay was performed on all isolates to identify β-lactamase-encoding genes. There were 83 unique episodes of monomicrobial CRE bacteremia during the study period: 37 (45%) CP-CRE and 46 (55%) non-CP-CRE. The majority of CP-CRE isolates were bla KPC (92%), followed by bla NDM (5%) and bla OXA-48-type (3%). CP-CRE isolates were more likely to have meropenem minimum inhibitory concentrations (MICs) ≥16 µg/mL, while non-CP-CRE isolates were more likely to have meropenem MICs ≤1 µg/mL (P value
Figures & Tables
  • References (25)
  • Citations (78)
📖 Papers frequently viewed together
181 Citations
537 Citations
25 Authors (Alice Guh, ..., Alexander J. Kallen)
115 Citations
78% of Scinapse members use related papers. After signing in, all features are FREE.
#1Pranita D. Tamma (JHUSOM: Johns Hopkins University School of Medicine)H-Index: 24
#2Yanjie Huang (Johns Hopkins University)H-Index: 2
Last. Patricia J. Simner (JHUSOM: Johns Hopkins University School of Medicine)H-Index: 18
view all 4 authors...
ABSTRACT Carbapenemase-producing (CP) Enterobacteriaceae are largely responsible for the rapid spread of carbapenem-resistant Enterobacteriaceae (CRE). Distinguishing CP-CRE from non-CP-CRE has important infection control implications. In a cohort of 198 CRE isolates, for isolates that remained susceptible or intermediate to some carbapenem antibiotics, an ertapenem MIC of 0.5 μg/ml and meropenem, imipenem, and doripenem MICs of 2 μg/ml were best able to distinguish CP-CRE from non-CP-CRE isolat...
10 CitationsSource
#2Christian PallaresH-Index: 5
Last. Manuel Guzman-BlancoH-Index: 14
view all 16 authors...
Introduction Infections caused by carbapenem-resistant Enterobacteriaceae are a public health problem associated with higher mortality rates, longer hospitalization and increased healthcare costs. We carried out a study to describe the characteristics of patients with carbapenemase-producing Enterobacteriaceae (CPE) and non-CPE bloodstream infection (BSI) from Latin American hospitals and to determine the clinical impact in terms of mortality and antibiotic therapy. Methods Between July 2013 and...
21 CitationsSource
#1Katherine E. Goodman (Johns Hopkins University)H-Index: 4
#2Patricia J. Simner (JHUSOM: Johns Hopkins University School of Medicine)H-Index: 18
Last. Aaron M. Milstone (Johns Hopkins University)H-Index: 29
view all 4 authors...
The Centers for Disease Control and Prevention (CDC) defines carbapenem-resistant Enterobacteriaceae (CRE) based upon a phenotypic demonstration of carbapenem resistance. However, considerable hete...
26 CitationsSource
#1Yedidah Fraenkel-Wandel (Shaare Zedek Medical Center)H-Index: 2
#2David Raveh-Brawer (Shaare Zedek Medical Center)H-Index: 2
Last. Marc Victor Assous (Shaare Zedek Medical Center)H-Index: 12
view all 5 authors...
To determine the mortality rate secondary to blaKPC Klebsiella pneumoniae (KPC/Kp) bacteraemia, compared with that from ESBL-producing K. pneumoniae (ESBL/Kp) bacteraemia, and to determine associated risk factors.This was a retrospective case-control study of all 68 KPC/Kp bacteraemia patients diagnosed since 2006, matched by year of isolation, gender and age, at a ratio of 1:2, to 136 ESBL/Kp bacteraemia patients.There were no demographic differences between the two groups, but there were minor...
24 CitationsSource
#1Nora Chea (CDC: Centers for Disease Control and Prevention)H-Index: 12
#2Sandra N. Bulens (CDC: Centers for Disease Control and Prevention)H-Index: 20
Last. Alexander J. Kallen (CDC: Centers for Disease Control and Prevention)H-Index: 33
view all 19 authors...
Preventing transmission of carbapenemase-producing, carbapenem-resistant Enterobacteriaceae (CP-CRE) is a public health priority. A phenotype-based definition that reliably identifies CP-CRE while minimizing misclassification of non–CP-CRE could help prevention efforts. To assess possible definitions, we evaluated enterobacterial isolates that had been tested and deemed nonsusceptible to >1 carbapenem at US Emerging Infections Program sites. We determined the number of non-CP isolates that met (...
28 CitationsSource
#1S. AmitH-Index: 1
#2Hagit MishaliH-Index: 5
Last. Yehuda CarmeliH-Index: 72
view all 5 authors...
Abstract Carriers of carbapenem-resistant Klebsiella pneumoniae (CRKP) are increasingly recognised through active surveillance in much of the world. We studied incidence, aetiology and predictors of bloodstream infections (BSI) among such carriers. Via a retrospective cohort study conducted in a tertiary care teaching hospital, we examined occurrence of BSI within 45 days of CRKP carrier detection. Three nested case-control studies were conducted to analyse parameters associated with all-cause (...
25 CitationsSource
#1Ilker Inanc Balkan (Istanbul University)H-Index: 12
#2Gokhan Aygun (Istanbul University)H-Index: 8
Last. Recep Ozturk (Istanbul University)H-Index: 28
view all 15 authors...
Summary Background Blood stream infections (BSIs) due to carbapenem-resistant Enterobacteriaceae (CRE) are associated with high hospital mortality rates and present a tremendous challenge to clinicians. The optimal treatment remains undefined. We aimed to investigate the risk factors for mortality and the correlation between different treatment modalities and outcomes. Methods The clinical characteristics and treatment outcomes of a cohort of 36 patients with BSIs due to CRE were investigated an...
35 CitationsSource
#1Matthaios Papadimitriou-Olivgeris (University of Patras)H-Index: 9
#2Markos Marangos (University of Patras)H-Index: 19
Last. Evangelos D. Anastassiou (University of Patras)H-Index: 20
view all 9 authors...
AbstractBackground: Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae (KPC-Kp) infections in intensive care units (ICUs) are associated with increased mortality. We aimed to determine risk factors for infection and predictors of 30-day mortality in ICU patients with KPC-Kp bloodstream infections (BSI).Methods: During a 26-month period, patients (n = 273) who stayed more than 6 days in the ICU of the University Hospital of Patras, Greece, were divided into 2 groups, those ...
31 CitationsSource
We evaluated the number of deaths attributable to carbapenem-resistant Enterobacteriaceae by using studies from around the world published before April 9, 2012. Attributable death was defined as the difference in all-cause deaths between patients with carbapenem-resistant infections and those with carbapenem-susceptible infections. Online databases were searched, and data were qualitatively synthesized and pooled in a metaanalysis. Nine studies met inclusion criteria: 6 retrospective case–contro...
210 CitationsSource
#1George L. Daikos (UoA: National and Kapodistrian University of Athens)H-Index: 37
#2Sophia Tsaousi (UoA: National and Kapodistrian University of Athens)H-Index: 1
Last. Athanasios Skoutelis (UoA: National and Kapodistrian University of Athens)H-Index: 21
view all 14 authors...
Carbapenemase-producing Klebsiella pneumoniae strains (CP-Kps) are currently among the most important nosocomial pathogens. An observational study was conducted during 2009 to 2010 in two hospitals located in a high-prevalence area (Athens, Greece). The aims were (i) to evaluate the clinical outcome of patients with CP-Kp bloodstream infections (BSIs), (ii) to identify predictors of mortality, and (iii) to evaluate the various antibiotic schemes employed. A total of 205 patients with CP-Kp BSIs ...
297 CitationsSource
Cited By78
#1Yuhang WangH-Index: 1
#2Jin WangH-Index: 1
Last. Yun CaiH-Index: 13
view all 4 authors...
Abstract Objectives Ceftazidime-avibactam (CAZ-AVI) is a novel synthetic β-lactamase inhibitor combination. Although the combination has been available clinically for only a few years, cases of resistance to CAZ-AVI have already been reported. Methods In the present review, we summarized the distribution of CAZ-AVI-resistant strains and the possible resistance mechanisms. Results There are no significant differences in CAZ-AVI resistance rates across different regions. CAZ-AVI maintains good act...
1 CitationsSource
#1Biying Zhang (Soochow University (Suzhou))
#2Zhichen Zhu (Soochow University (Suzhou))
Last. Hong Du (Soochow University (Suzhou))H-Index: 6
view all 10 authors...
Abstract Objectives To study the molecular epidemiology of clinical MBL-Enterobacteriaceae isolates in China and to evaluate the antimicrobial susceptibility of aztreonam-avibactam against MBL-Enterobacteriaceae isolates. Methods Bacterial speciation was determined using the MALDI-TOF MS apparatus. PCR was used to screen common carbapenemase genes. Antimicrobial susceptibility testing of common clinical antibiotics and aztreonam-avibactam was performed by standard broth microdilution method. Res...
#2Özge Turhan (Akdeniz University)H-Index: 14
Last. Latife Mamikoglu (Akdeniz University)H-Index: 8
view all 9 authors...
OBJECTIVE: The aim of this study was to investigate the prevalence of carbapenemase and CTX-M genes among 330 blood culture isolates of Enterobacterales with reduced susceptibility to at least 1 carbapenem, between 2010 and 2015. METHODS: BD Max CRE assay and in-house PCR were used to detect carbapenemase and CTX-M genes. RESULTS: At least 1 carbapenemase gene was detected among 113 (74.3%) of the 152 carbapenem resistant isolates. The OXA-48 (69.7%) was the most common carbapenemase followed by...
#1Wei Cheng (Peking Union Medical College Hospital)
#2Hao Wang (Peking Union Medical College Hospital)H-Index: 7
Last. Na Cui (Peking Union Medical College Hospital)H-Index: 6
view all 7 authors...
Abstract Objectives This work investigated the utility of lymphocyte subset counts as a diagnostic and prognostic marker for carbapenem-resistant Enterobacteriaceae (CRE) infection. Methods We assessed the lymphocyte subset populations and other clinical parameters of septic patients upon intensive care unit (ICU) admission and evaluated their potential impact on CRE infection diagnosis and outcome. Results Among 373 septic patients, 51 were diagnosed with CRE infection. The 28-day mortality was...
Introduction: Carbapenem-resistant Enterobacterales (CRE) represent a global public health problem. Precision medicine (PM) is a multicomponent medical approach that should be used to individualize the management of patients infected with CRE.Areas covered: Here, we differentiate carbapenem-producing CRE (CP-CRE) from non-CP-CRE and the importance of this distinction in clinical practice. The current phenotypic CRE-case definition and its implications are also discussed. Additionally, we summari...
#1Abdul Wasey (Northwest University (United States))
#2Jianhua Yang (Northwest University (United States))
Last. Ce Zhang (Northwest University (United States))H-Index: 2
view all 5 authors...
Abstract Given the great threat posed by clinical Carbapenemase-producing Enterobacteriaceae (CPE), its rapid and accurate detection is highly required to guide infection treatment and to prevent serious outbreaks. While the Carba NP test (CNPt) is a popular and methodologically simple colorimetric assay for detecting carbapenemase activity, its clinical application is limited by low throughput, poor sensitivity and obscure color interpretation due to the lack of quantitative information on time...
#1Jiwon Jung (UOU: University of Ulsan)H-Index: 12
#1Jiwon Jung (Asan Medical Center)H-Index: 1
Last. Yang Soo Kim (Asan Medical Center)H-Index: 99
view all 12 authors...
Abstract Background Concerns are growing over the importance of the hospital water environment for the transmission of carbapenemase-producing Enterobacteriaceae (CPE). Aim We report a large outbreak in the cardiology units involving intensive care units (ICU) and wards at a tertiary care hospital. Methods Contact tracing, case-control study to find the risk factors for acquisition of CPE and environmental sampling were performed during a CPE outbreak between July and December 2018. Findings A t...
#1Nathan G. Schoepp (California Institute of Technology)H-Index: 9
#2Eric J. Liaw (California Institute of Technology)H-Index: 2
Last. Rustem F. Ismagilov (California Institute of Technology)H-Index: 63
view all 6 authors...
The rise in carbapenem-resistant Enterobacteriaceae (CRE) infections has created a global health emergency, underlining the critical need to develop faster diagnostics to treat swiftly and correctly. Although rapid pathogen-identification (ID) tests are being developed, gold-standard antibiotic susceptibility testing (AST) remains unacceptably slow (1–2 d), and innovative approaches for rapid phenotypic ASTs for CREs are urgently needed. Motivated by this need, in this manuscript we tested the h...
1 CitationsSource
#1Jiao Liu (SJTU: Shanghai Jiao Tong University)H-Index: 3
#1Jiao Liu (SJTU: Shanghai Jiao Tong University)
Last. Long LiuH-Index: 1
view all 16 authors...
BACKGROUND: Carbapenem-resistant Enterobacteriaceae (CRE) infections are associated with poor patient outcomes. Data on risk factors and molecular epidemiology of CRE in complicated intra-abdominal infections (cIAI) in China are limited. This study examined the risk factors of cIAI with CRE and the associated mortality based on carbapenem resistance mechanisms. METHODS: In this retrospective analysis, we identified 1024 cIAI patients hospitalized from January 1, 2013 to October 31, 2018 in 14 in...
1 CitationsSource
#1Sumanth Gandra (WashU: Washington University in St. Louis)H-Index: 17
#2Carey-Ann D. Burnham (WashU: Washington University in St. Louis)H-Index: 26